Search Results - "Bacher, U."

3D CONTENT GENERATION USING HYBRID AERIAL SENSOR DATA.

Authors: Bacher, U.

Source: International Archives of the Photogrammetry, Remote Sensing & Spatial Information Sciences; 2021, Issue B2, p297-303, 7p

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

Authors: Klyuchnikov, E Bacher, U Kroll, T et al.

Source: Bone Marrow Transplantation. Jan2014, Vol. 49 Issue 1, p1-7. 7p. 1 Diagram, 2 Charts.

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

Authors: Grossmann, V Bacher, U Haferlach, C et al.

Source: Leukemia (08876924). Sep2013, Vol. 27 Issue 9, p1940-1943. 4p. 1 Diagram, 2 Charts.

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.

Authors: Meggendorfer, M Bacher, U Alpermann, T et al.

Source: Leukemia (08876924). Sep2013, Vol. 27 Issue 9, p1852-1860. 9p. 2 Diagrams, 3 Charts, 1 Graph.

Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype.

Authors: Bacher, U Haferlach, T Alpermann, T et al.

Source: Leukemia (08876924). Feb2013, Vol. 27 Issue 2, p496-500. 5p. 2 Charts, 1 Graph.

Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.

Authors: Bacher, U. Kern, W. Alpermann, T. et al.

Source: Leukemia (08876924). Aug2011, Vol. 25 Issue 8, p1361-1364. 4p. 1 Chart, 1 Graph.

Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.

Authors: Schnittger, S. Bacher, U. Kern, W. et al.

Source: Leukemia (08876924). Aug2011, Vol. 25 Issue 8, p1297-1304. 8p. 3 Charts, 3 Graphs.

The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML.

Authors: Haferlach, C. Bacher, U. Haferlach, T. et al.

Source: Leukemia (08876924). May2011, Vol. 25 Issue 5, p874-877. 4p. 1 Chart, 1 Graph.

Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.

Authors: Schnittger, S. Bacher, U. Haferlach, C. et al.

Source: Leukemia (08876924). Apr2011, Vol. 25 Issue 4, p615-621. 7p. 4 Charts, 2 Graphs.

Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.

Authors: Neth, O. W. Bacher, U. Das, P. et al.

Source: Bone Marrow Transplantation. Jan2010, Vol. 45 Issue 1, p13-19. 7p. 2 Charts, 4 Graphs.

Interactive diagnostics in the indication to allogeneic SCT in AML.

Authors: Bacher, U. Haferlach, C. Schnittger, S. et al.

Source: Bone Marrow Transplantation. May2009, Vol. 43 Issue 10, p745-756. 12p. 1 Diagram, 2 Charts.

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

Authors: Bacher, U. Zander, A. R. Haferlach, T. et al.

Source: Bone Marrow Transplantation. Aug2008, Vol. 42 Issue 3, p145-157. 13p. 1 Chart.

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients

Authors: Schnittger, S. Bacher, U. Haferlach, C. et al.

Source: Leukemia (08876924). Apr2007, Vol. 21 Issue 4, p725-731. 7p. 4 Charts, 2 Graphs.

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.

Authors: Bacher, U Hochhaus, A Berger, U et al.

Source: Leukemia (08876924). Mar2005, Vol. 19 Issue 3, p460-463. 4p.

Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment.

Authors: Haferlach, C Bacher, U Schnittger, S et al.

Source: Leukemia (08876924). Mar2010, Vol. 24 Issue 3, p638-640. 3p. 1 Diagram.

A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.

Authors: Schnittger, S. Bacher, U. Kern, W. et al.

Source: Leukemia (08876924). Apr2008, Vol. 22 Issue 4, p856-858. 3p. 1 Diagram, 1 Chart, 1 Graph.

Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis.

Authors: Schnittger, S. Bacher, U. Haferlach, C. et al.

Source: Leukemia (08876924). Feb2008, Vol. 22 Issue 2, p453-455. 3p. 1 Color Photograph, 1 Graph.

JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.

Authors: Schnittger, S. Bacher, U. Kern, W. et al.

Source: Leukemia (08876924). Aug2007, Vol. 21 Issue 8, p1843-1845. 3p. 2 Charts.

Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E.

Authors: Schnittger, S. Bacher, U. Kern, W. et al.

Source: Leukemia (08876924). Dec2006, Vol. 20 Issue 12, p2195-2197. 3p. 1 Graph.

directCell: Hybrid systems with tightly coupled accelerators.

Authors: Penner, H. Bacher, U. Kunigk, J. et al.

Source: IBM Journal of Research & Development. Sep2009, Vol. 53 Issue 5, p2:1-2:13. 13p.

Subjects: IBM Systems Application Architecture, Microprocessor programming, IBM computer peripherals, International Business Machines Corp., Hybrid systems, Computer operating systems, Client/server computing, PCI bus (Computer bus)